Gersowitz Libo & Korek, P.C. is investigating cases alleging the increased risk of cancer due to the weight loss drug Belviq and Belviq XR (“Belviq”). On February 13, 2020, the FDA announced that Eisai Inc. is voluntarily recalling the prescription drug Belviq from the U.S. market. The announcement was made after studies revealed elevated cancer risks among patients taking the weight loss drug.
If you or a loved one has used the drug Belviq and was diagnosed with cancer, you may be entitled to compensation from the drug manufacturer. Gersowitz Libo & Korek, P.C. is currently investigating and accepting claims on behalf of any individuals who have been diagnosed with cancer after having taken Belviq. For more information or to schedule a complimentary consultation with one of our New York Belviq lawsuit attorneys, please call Gersowitz Libo & Korek, P.C. at 1-646-798-1535.
What Is Belviq?
Belviq is a prescription weight loss drug manufactured by Eisai, Inc. The drug was approved by the FDA in 2012 to treat obesity. The active ingredient, lorcaserin, promotes weight loss by altering signals in the patient’s brain to trigger loss of appetite and hunger. These chemical changes increases feeling of fullness – convincing the brain and body to reduce the intake of calorie and consume much less than the individual normally would. It was available by prescription in its original form and in an extended release version, Belviq X. Both are the subject of the Belviq lawsuits.
The FDA announced in February that Eisai, Inc. had voluntarily recalled the drug. This recall came after the FDA completed its review of the results from the recent CAMELLIA-TIMI 61 clinical trial by Eisai, Inc. that revealed an unacceptable increased risk of cancer with Belviq. The manufacturer had failed to warn physicians and patients of the dangers. The FDA further announced that the risks of using Belviq outweighs any benefits it may have had and recommends that patients stop taking Belviq immediately.
Eligibility for the Belviq Recall Lawsuit
If you or a loved one has taken Belviq and has been diagnosed with any type of cancer, you may be entitled to monetary compensation from the drug manufacturer, Eisai, Inc. You should immediately consult with a New York Belviq lawsuit attorney if you:
- Have taken Belviq or Belviq XR regularly for at least 3 months.
- Were diagnosed with pancreatic, colorectal, or lung cancers at least 6 months after your first use of the drug.
- Were younger than 60 years old at the time of the cancer diagnosis.
If you meet any of these requirements, you should discuss your case and the possibility of compensation with an attorney. However, even if you do not meet the criteria, you should still speak with an attorney to determine if there is any legal recourse.
Take Legal Action
Gersowitz Libo & Korek, P.C. is currently investigating legal claims involving victims who have cancer after taking Belviq.
If you or someone you care about has been diagnosed with cancer after taking the prescription drug Belviq, you may be entitled to compensation. To protect your legal rights and get the full money damages you are entitled to, you need to immediately consult with an experienced New York Belviq lawsuit attorney.
To learn more, contact the legal team at Gersowitz Libo & Korek, P.C. today at 1-646-798-1535. Our case managers will listen to your facts and help you understand your options.
